Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies: Insights From Randomized Controlled Trials

JACC: Cardiovascular Imaging

Volumn 10, Issue 3, 2017, Pages 230-240

  Bulluck, Heerajnarain ^a,b,c   Hammond Haley, Matthew ^a   Weinmann, Shane ^a   Martinez Macias, Roberto ^a   Hausenloy, Derek J ^a,b,c,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c DEPARTMENT OF CARDIOLOGY   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

cardiovascular magnetic resonance; myocardial infarct size; primary percutaneous coronary intervention; randomized controlled trial; sample size; ST segment elevation myocardial infarction

Indexed keywords

GADOBUTROL; GADOLINIUM PENTETATE MEGLUMINE; GADOTERATE MEGLUMINE; CONTRAST MEDIUM; GADOLINIUM;

ARTICLE; BLOOD CLOT LYSIS; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART PROTECTION; HUMAN; IMAGE ANALYSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; META ANALYSIS; MULTICENTER STUDY (TOPIC); NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; CARDIAC MUSCLE; DIAGNOSTIC IMAGING; EVIDENCE BASED MEDICINE; HEART MUSCLE REPERFUSION; METHODOLOGY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; ST ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

CONTRAST MEDIA; EVIDENCE-BASED MEDICINE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL REPERFUSION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; ST ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

EID: 85014452264     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2017.01.008     Document Type: Article

References (46)

1. 1 Jimenez-Candil, J., Diaz-Castro, O., Barrabes, J.A., et al. Update on ischemic heart disease and critical care cardiology. Rev Esp Cardiol 66 (2013), 198–204.
2. 2 Torabi, A., Cleland, J.G., Khan, N.K., et al. The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Eur Heart J 29 (2008), 859–870.
3. 3 Desch, S., Eitel, I., de Waha, S., et al. Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction. Trials, 12, 2011, 204.
4. 4 Schulz-Menger, J., Bluemke, D.A., Bremerich, J., et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on standardized Post Processing. J Cardiovasc Magn Reson, 15, 2013, 35.
5. 5 Stone, G.W., Selker, H.P., Thiele, H., et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol 67 (2016), 1674–1683.
6. 6 Hamirani, Y.S., Wong, A., Kramer, C.M., Salerno, M., Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol Img 7 (2014), 940–952.
7. 7 Eitel, I., Desch, S., Fuernau, G., et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 55 (2010), 2470–2479.
8. 8 Desch, S., Engelhardt, H., Meissner, J., et al. Reliability of myocardial salvage assessment by cardiac magnetic resonance imaging in acute reperfused myocardial infarction. Int J Cardiovasc Imaging 28 (2012), 263–272.
9. 9 Bellenger, N.G., Grothues, F., Smith, G.C., Pennell, D.J., Quantification of right and left ventricular function by cardiovascular magnetic resonance. Herz 25 (2000), 392–399.
10. 10 van Kranenburg, M., Magro, M., Thiele, H., et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. J Am Coll Cardiol Img 7 (2014), 930–939.
11. 11 Thiele, H., Kappl, M.J., Conradi, S., Niebauer, J., Hambrecht, R., Schuler, G., Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol 47 (2006), 1641–1645.
12. 12 Lonborg, J., Vejlstrup, N., Mathiasen, A.B., Thomsen, C., Jensen, J.S., Engstrom, T., Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: reproducibility and comparison of two T2-weighted protocols. J Cardiovasc Magn Reson, 13, 2011, 50.
13. 13 White, H.D., Norris, R.M., Brown, M.A., Brandt, P.W.T., Whitlock, R.M.L., Wild, C.J., Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987), 44–51.
14. 14 Hadamitzky, M., Langhans, B., Hausleiter, J., et al. Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-sestamibi. Eur Heart J Cardiovasc Imaging 15 (2014), 216–225.
15. 15 Eitel, I., de Waha, S., Wohrle, J., et al. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol 64 (2014), 1217–1226.
16. 16 Bulluck, H., White, S.K., Rosmini, S., et al. T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients. J Cardiovasc Magn Reson, 17, 2015, 73.
17. 17 Bulluck, H., Rosmini, S., Abdel-Gadir, A., et al. Automated extracellular volume fraction mapping provides insights into the pathophysiology of left ventricular remodeling post-reperfused ST-elevation myocardial infarction. J Am Heart Assoc, 5, 2016, e003555.
18. 18 Carberry, J., Carrick, D., Haig, C., et al. Remote zone extracellular volume and left ventricular remodeling in survivors of ST-elevation myocardial infarction. Hypertension 68 (2016), 385–391.
19. 19 Bulluck, H., Rosmini, S., Abdel-Gadir, A., et al. Residual myocardial iron following intramyocardial hemorrhage during the convalescent phase of reperfused ST-segment–elevation myocardial infarction and adverse left ventricular remodeling. Circ Cardiovasc Imaging, 9, 2016, e004940.
20. 20 Carrick, D., Haig, C., Ahmed, N., et al. Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction: relation to microvascular obstruction and prognostic significance. Circ Cardiovasc Imaging, 9, 2016, e004148.
21. 21 Wright, J., Adriaenssens, T., Dymarkowski, S., Desmet, W., Bogaert, J., Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrast-enhanced CMR and coronary angiography. J Am Coll Cardiol Img 2 (2009), 825–831.
22. 22 Carrick, D., Haig, C., Rauhalammi, S., et al. Pathophysiology of LV remodeling in survivors of STEMI: inflammation, remote myocardium, and prognosis. J Am Coll Cardiol Img 8 (2015), 779–789.
23. 23 Jaarsma, C., Schalla, S., Cheriex, E.C., et al. Incremental value of cardiovascular magnetic resonance over echocardiography in the detection of acute and chronic myocardial infarction. J Cardiovasc Magn Reson, 15, 2013, 5.
24. 24 Yan, A.T., Shayne, A.J., Brown, K.A., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114 (2006), 32–39.
25. 25 Carrick, D., Haig, C., Rauhalammi, S., et al. Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. Eur Heart J 37 (2016), 1044–1059.
26. 26 Kwong, R.Y., Sattar, H., Wu, H., et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 118 (2008), 1011–1020.
27. 27 Jablonowski, R., Engblom, H., Kanski, M., et al. Contrast-enhanced CMR overestimates early myocardial infarct size: mechanistic insights using ECV measurements on day 1 and day 7. J Am Coll Cardiol Img 8 (2015), 1379–1389.
28. 28 Dall'Armellina, E., Karia, N., Lindsay, A.C., et al. Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ Cardiovasc Imaging 4 (2011), 228–236.
29. 29 Ibrahim, T., Hackl, T., Nekolla, S.G., et al. Acute myocardial infarction: serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion. Radiology 254 (2010), 88–97.
30. 30 Carrick, D., Haig, C., Ahmed, N., et al. Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-segment elevation myocardial infarction: pathophysiological insights and clinical implications. J Am Heart Assoc, 5, 2016, e002834.
31. 31 Orn, S., Manhenke, C., Greve, O.J., et al. Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. Eur Heart J 30 (2009), 1978–1985.
32. 32 Verhaert, D., Thavendiranathan, P., Giri, S., et al. Direct T2 quantification of myocardial edema in acute ischemic injury. J Am Coll Cardiol Img 4 (2011), 269–278.
33. 33 Fernandez-Jimenez, R., Sanchez-Gonzalez, J., Aguero, J., et al. Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization. J Am Coll Cardiol 65 (2015), 315–323.
34. 34 Kim, H.W., Van Assche, L., Jennings, R.B., et al. Relationship of T2-weighted MRI myocardial hyperintensity and the ischemic area-at-risk. Circ Res 117 (2015), 254–265.
35. 35 Durmus, T., Schilling, R., Doeblin, P., et al. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction intraindividual comparison with gadopentetate dimeglumine. Invest Radiol 47 (2012), 183–188.
36. 36 Wagner, M., Schilling, R., Doeblin, P., et al. Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gadoterate meglumine. Eur Radiol 23 (2013), 108–114.
37. 37 Hammer-Hansen, S., Bandettini, W.P., Hsu, L.Y., et al. Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: a quantitative and kinetic study. Eur Heart J Cardiovasc Imaging 17 (2016), 76–84.
38. 38 Rodriguez-Palomares, J.F., Ortiz-Perez, J.T., Lee, D.C., et al. Time elapsed after contrast injection is crucial to determine infarct transmurality and myocardial functional recovery after an acute myocardial infarction. J Cardiovasc Magn Reson, 17, 2015, 43.
39. 39 Flett, A.S., Hasleton, J., Cook, C., et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. J Am Coll Cardiol Img 4 (2011), 150–156.
40. 40 Vermes, E., Childs, H., Carbone, I., Barckow, P., Friedrich, M.G., Auto-threshold quantification of late gadolinium enhancement in patients with acute heart disease. J Magn Reson Imaging 37 (2013), 382–390.
41. 41 Bondarenko, O., Beek, A.M., Hofman, M.B., et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 7 (2005), 481–485.
42. 42 Bulluck, H., Rosmini, S., Abdel-Gadir, A., et al. Impact of microvascular obstruction on semi-automated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance. Open Heart, 3, 2016, e000535.
43. 43 Khan, J.N., Nazir, S.A., Horsfield, M.A., et al. Comparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5T and 3.0T field strengths. BMC Res Notes, 8, 2015, 52.
44. 44 Beek, A.M., Bondarenko, O., Afsharzada, F., van Rossum, A.C., Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome. J Cardiovasc Magn Reson, 11, 2009, 6.
45. 45 Botker, H.E., Kaltoft, A.K., Pedersen, S.F., Kim, W.Y., Measuring myocardial salvage. Cardiovasc Res 94 (2012), 266–275.
46. 46 Engblom, H., Heiberg, E., Erlinge, D., et al. Sample size in clinical cardioprotection trials using myocardial salvage index, infarct size, or biochemical markers as endpoint. J Am Heart Assoc, 5, 2016, e002708.